Kyowa Kirin Co., Ltd.
Pharmaceuticals
Company Summary
Kyowa Kirin Co., Ltd. develops and distributes medications for oncology, nephrology, the central nervous system, and immunology around the world. The company's headquarters are in Tokyo, Japan, where it was formed in 1949.
Website : https://www.kyowakirin.com/
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
24.4
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
Refinitiv
Overall ESG Rating :
78
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
MSCI
Overall ESG Rating :
AA
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader
Kyowa Kirin is a leader among 76 companies in the pharmaceuticals industry.
Temperature Rise :
1.3℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned
